alexa Exploring Paraoxonases/lactonases As A Tool To Interfere With Pseudomonas Aeruginosa Infection | 17213
ISSN: 2155-952X

Journal of Biotechnology & Biomaterials
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Share This Page

Exploring paraoxonases/lactonases as a tool to interfere with Pseudomonas aeruginosa infection

5th World Congress on Biotechnology

Luigi Mandrich, Elena Porzio, Davide Andrenacci and Giuseppe Manco

Posters: J Biotechnol Biomater

DOI: 10.4172/2155-952X.S1.028

Abstract
Pseudomonas aeruginosa is the major cause of clinically relevant infections in cystic fibrosis (CF) due the antibiotic resistance, which demands for new strategies of microbe proliferation control. CF represents a model biofilm infection. During the course of CF, P. aeruginosa starts to produce exo-polysaccharides and forms biofilm characterized by cellular aggregates embedded within the mucus layer present in the airways. Biofilm formation in the CF lung is controlled by bacterial quorum- sensing (QS) mechanisms. QS signaling can be disrupted by lactonases. Three lactonases are present in human: PON1, PON2 and PON3; among these only PON2 is expressed in all tissues and in airways epithelial cells it seem to be involved in the first step of defense against bacterial infection. P. aeruginosa uses acyl-homoserine lactone (HSL) quorum sensing molecules, prevalently 3OC12-HSL, to regulate the expression of genes implicated in virulence and biofilm formation. It has been shown that all the human PONs can inactivate 3OC12-HSL. We have started studying thermostable members of the newly identified family of phosphotriesterase-like lactonase (PLL) and PON2 as mean to counteract P. aeruginosa infection in vitro and in vivo animal model ( Drosophila ). Evidences were obtained that thermostable PLLs reduce the production of virulence factors in vitro . An engineered version of PON2 has been designed and expressed in E. coli , purified, characterisedand used in in vitro tests.
Biography
Luigi Mandrich is currently a staff researcher at the Institute of Protein Biochemistry of the National Research Council. He graduated in Biological Sciences at the University of Naples ?Federico II?, and in 2004 received the PhD in Industrial Biotechnology.During his training he moved to The Netherland and Argentina to exploit new approaches to the use of exogenous enzymes in cheese making. He has carried out research in the field of biochemistry, and enzymes biotechnological applications. He is involved in research projects concerning the technology of recombinant DNA to produce and study human and bacterial proteins involved in detoxification of pesticides and to counteract pathogens infections. He is co-author of more than 40 papers on international peer reviewed journals, and he is Editor of the ?Cloning and Transgenesis? journal.
Top